Return to Trial Database

BTCRC-GU14-003

Phase Ib and Phase II Studies of Anti-PD-1 Antibody MK-3475 in Combination With Bevacizumab for the Treatment of Metastatic Renal Cell Carcinoma: Big Ten Cancer Research Consortium GU14-003

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial BTCRC-GU14-003 being conducted in.

No data was found